Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Pulnovo Medical raises $100M in oversubscribed round led by Medtronic to advance pulmonary hypertension therapy.
MDT
$81.25
+$1.95 +2.47%

Pulnovo Medical raises $100M in oversubscribed round led by Medtronic to advance pulmonary hypertension therapy.

Company Fundamentals
19 Apr 2026
PRNewsWire
View Source
Bullish
pluang ai news

Pulnovo Medical secured $100 million in a strategic financing round led by Medtronic and supported by existing and new global investors. The funding will accelerate clinical development, regulatory approvals, and commercialization of Pulnovo's Pulmonary Artery Denervation (PADN) System, a minimally invasive therapy for pulmonary hypertension and heart failure. Pulnovo has performed about 1,500 PADN procedures globally and holds regulatory approvals in seven countries, with ongoing trials in the U.S. and other regions. This financing marks a shift toward a global growth platform, supported by new leadership and a commercial agreement with Medtronic to leverage global market reach.

More News (MDT)

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...

Market News
Bullish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App